We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-4.46%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$10.5B
AUM Growth
+$4.68B
Cap. Flow
+$4.98B
Cap. Flow %
47.59%
Top 10 Hldgs %
29.39%
Holding
7,240
New
774
Increased
2,864
Reduced
2,421
Closed
823

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$413M
2
MSFT icon
Microsoft
MSFT
+$342M
3
AMZN icon
Amazon
AMZN
+$210M
4
TSLA icon
Tesla
TSLA
+$130M
5
NVDA icon
NVIDIA
NVDA
+$126M

Top Sells

Rank Stock Value
1
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$51.9M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$45.1M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$34.7M
4
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$27.3M
5
IWB icon
iShares Russell 1000 ETF
IWB
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 30.51%
2 Consumer Discretionary 11.8%
3 Healthcare 9.84%
4 Communication Services 9.47%
5 Financials 9.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVLV icon
1326
Revolve Group
RVLV
$1.7B
$372K ﹤0.01%
6,929
+4,955
+251% +$252K
SLAB icon
1327
Silicon Laboratories
SLAB
$7.22B
$372K ﹤0.01%
2,475
-644
-21% -$103K
PXI icon
1328
Invesco Dorsey Wright Energy Momentum ETF
PXI
$53.7M
$371K ﹤0.01%
8,685
-27,844
-76% -$1.03M
AMPH icon
1329
Amphastar Pharmaceuticals
AMPH
$861M
$370K ﹤0.01%
10,283
+9,196
+846% +$261K
EQAL icon
1330
Invesco Russell 1000 Equal Weight ETF
EQAL
$841M
$370K ﹤0.01%
+7,950
New +$361K
MEOH icon
1331
Methanex
MEOH
$4.28B
$370K ﹤0.01%
6,771
+6,437
+1,927% +$315K
IHE icon
1332
iShares US Pharmaceuticals ETF
IHE
$1.65B
$369K ﹤0.01%
+5,694
New +$361K
SGI
1333
Somnigroup International
SGI
$14B
$369K ﹤0.01%
13,234
-6,596
-33% -$243K
CEQP
1334
DELISTED
Crestwood Equity Partners LP
CEQP
$369K ﹤0.01%
12,344
+12,300
+27,955% +$361K
ARRY icon
1335
Array Technologies
ARRY
$821M
$368K ﹤0.01%
32,643
+19,189
+143% +$216K
CRNX icon
1336
Crinetics Pharmaceuticals
CRNX
$8.94B
$368K ﹤0.01%
16,744
+13,226
+376% +$268K
URBN icon
1337
Urban Outfitters
URBN
$6.74B
$368K ﹤0.01%
14,656
+8,342
+132% +$228K
DCP
1338
DELISTED
DCP Midstream, LP
DCP
$368K ﹤0.01%
10,949
-6,996
-39% -$215K
CRH icon
1339
CRH
CRH
$67.1B
$367K ﹤0.01%
9,160
+9,092
+13,371% +$433K
DASH icon
1340
DoorDash
DASH
$93.4B
$367K ﹤0.01%
3,130
-671
-18% -$72.6K
VRS
1341
DELISTED
Verso Corporation
VRS
$367K ﹤0.01%
13,580
+8,060
+146% +$215K
BIS icon
1342
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.06M
$366K ﹤0.01%
7,589
-2,303
-23% -$118K
SPWH icon
1343
Sportsman's Warehouse
SPWH
$46.8M
$366K ﹤0.01%
34,287
+33,967
+10,615% +$380K
AESC
1344
DELISTED
The AES Corporation
AESC
$366K ﹤0.01%
3,700
+2,929
+380% +$267K
REPL icon
1345
Replimune Group
REPL
$1.17B
$365K ﹤0.01%
21,495
+16,555
+335% +$312K
UNM icon
1346
Unum
UNM
$14.4B
$364K ﹤0.01%
11,530
+2,199
+24% +$61.4K
DVAX
1347
DELISTED
Dynavax Technologies
DVAX
$363K ﹤0.01%
33,516
+4,407
+15% +$53.5K
ORGO icon
1348
Organogenesis Holdings
ORGO
$234M
$362K ﹤0.01%
47,472
+21,083
+80% +$163K
WPC icon
1349
W.P. Carey
WPC
$16B
$362K ﹤0.01%
4,566
-4,286
-48% -$329K
LGIH icon
1350
LGI Homes
LGIH
$1.33B
$361K ﹤0.01%
3,701
+3,416
+1,199% +$422K
52 53
54
55 56

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2022 Portfolio in Review

As of Q1 2022, Tower Research Capital (TRC) held 7,240 positions worth $10.5B, up 81% from $5.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $4.98B of net new capital in Q1 2022, opening 774 new positions and adding to 2,864 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $45.1M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2022 buy was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2022, an estimated $413M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $45.1M.
  • Tower Research Capital (TRC) fully exited State Street Technology Select Sector SPDR ETF in Q1 2022, selling an estimated $51.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $10.5B portfolio in Q1 2022.
  • Tower Research Capital (TRC) opened 774 new positions and closed 823 in Q1 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 81% quarter-over-quarter to $10.5B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.